Theratechnologies Receives FDA Approval of Prior Approval Supplement (PAS) for EGRIFTA SV® sBLA

Stock Information for Velan Inc. Subordinate Voting Shares

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Velan Inc. Subordinate Voting Shares

Theratechnologies Reports Financial Results for the Second Quarter 2025
Theratechnologies to Announce Second Quarter 2025 Financial Results
Theratechnologies enters into Definitive Agreement to be Acquired by CB Biotechnology, an Affiliate of Future Pak
Theratechnologies Reports on its Annual Meeting of Shareholders
Theratechnologies Presents Novel Data at ACTHIV 2025 Underscoring Importance of Managing Excess Visceral Abdominal Fat (EVAF) in People with HIV
Theratechnologies Provides Update on Sale Process
Theratechnologies Responds to Future Pak's Press Release and Announces Exclusive Discussions with Another Potential Acquiror for the Sale of the Company
Theratechnologies Reports Financial Results for the First Quarter 2025 and Reviews Key Achievements

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.